TP53 and melanoma: To determine if the effects of PKM2 deletion on T cell phenotype were not limited to a KrasG12D/+ p53−/− model of NSCLC, we employed the B16F10 melanoma model expressing Ova257 – 264 and GFP, B16F10-ova-GFP.